Andere Sprachen Seegene, Inc.

Aktien

A096530

KR7096530001

A096530

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 03.06.2024			% 5 Tage	% 1. Jan.
21.250 ^KRW	+0,47 %		-0,70 %	-7,21 %

14.03.	Seegene, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
24.01.	Seegene Inc. kündigt Zusammenarbeit mit Microsoft an, um eine Welt frei von allen Krankheiten zu verwirklichen	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases	24.01.
Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14.08.23
Seegene Inc. Unveils Solutions to Popularize Molecular Diagnostics At 2023 AACC	31.07.23
Seegene, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.	13.07.23
Seegene, Inc. authorizes a Buyback Plan.	13.07.23
Seegene, Inc. and Werfen Partner to Collaborate on Onesystem Business to Develop Syndromic qPCR Assays	14.06.23
Seegene and Werfen Partner to Collaborate on OneSystem(TM) Business to Develop Syndromic qPCR Assays	14.06.23
Seegene, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15.05.23
Seegene, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares.	28.02.23
Seegene, Inc. authorizes a Buyback Plan.	28.02.23
Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14.11.22
Seegene, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares.	28.09.22
Seegene, Inc. authorizes a Buyback Plan.	28.09.22
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16.08.22
Seegene, Inc. to Pave Way for PCR Testing At Local Clinics with EU-Approved Multiplex Test and Fully Automated PCR Solution	29.06.22
Seegene Obtains EU Approval for its Allplex SARS-CoV-2/FluA/FluB/RSV Assay	29.06.22
Seegene Inc. Develops PCR Test to Detect Monkeypox Virus	28.06.22
Seegene, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16.05.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Seegene, Inc.

Aktien

A096530

KR7096530001

A096530

Andere Sprachen

Filter